• Info
  • Insider Trading

Denise Scots-Knight - Insider Trading & Ownership

Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Summary
The estimated net worth of Denise Scots-Knight is at least $6.24M dollars as of December 2, 2025. Denise Scots-Knight is the Chief Executive Officer of Mereo BioPharma Group plc and owns shares of Mereo BioPharma Group plc (MREO) stock worth about $4.25M. Denise Scots-Knight is the Director of Elanco Animal Health Inc and owns shares of Elanco Animal Health Inc (ELAN) stock worth about $2M.
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Denise K. Scots-Knight
All Insider Reports
All Insider Reports

Notify me when Denise Scots-Knight files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Denise Scots-Knight

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MREO Mereo BioPharma Group plc Chief Executive Officer $4.25M Jan 25, 2025
ELAN Elanco Animal Health Inc Director $2M Nov 28, 2025

Insider Transactions Reported by Denise Scots-Knight:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.